OrthoSonos

Total joint replacement has become a widely accepted treatment for many destructive joint diseases.

Failure of the two most commonly and most successfully replaced joints, the knee and the hip, occur due to infection, or to wear of the joint’s weight bearing surfaces which generates debris. In response to this debris, a biological reaction occurs that eventually leads to implant failure.

The required surgical revision can be severely complicated by progressing tissue damage: bone loss, pseudotumors, adverse local tissue reaction, necrosis, muscle mass loss, to name a few. Stage I and II Osteoarthritis and implant failure are not well detected by radiography and conventional MRI techniques1.

1. Oei EH1, et. al. Quantitative radiological imaging techniques for articular cartilage composition: Towards early diagnosis and development of disease-modifying therapeutics for osteoarthritis., Arthritis Care Res (Hoboken). 2014 Feb 27. doi: 10.1002/acr.22316


OrthoSonos Features:

  • Assessment performed through full dynamic range of joint motion, rather than current, static view
  • Non-invasive
  • Continuous or single use monitoring
  • Single reported metric of joint friction: the OrthoSonos Health Index

Bruin Biometrics LLC


Existing patents
OrthoSonos patents issued as of October 2016

U.S. D805,646
U.S. D852,649
U.S. D814641
EU 003419035-0001 to 0008
EU 003477082-0001 & 0002
EU 003465871-0001 & 0002
Canada 171130
Canada 174434
Canada 171765
Canada 174230
Canada 171764
Canada 174433

OrthoSonos is not yet available for sale.


Have questions about our company, products or pipeline? We'd like to hear from you.

Contact us